Key points:
The Stoxx 600 is attempting to rally, but it is still too early to turn positive. In order for us to move bullish, we are looking for a follow-through day, rising volume, and for leadership to emerge. We are not there yet and the index remains in a Rally Attempt.
Our Focus List is a good indicator of market health. The decreasing number of ideas reflects our cautious stance toward European equities. We have been lightening up our exposure to Cyclical and, adversely, strengthening our exposure to Health Care.
Actionable Focus List ideas in Healthcare include: Ipsen ( IPN.FR ) and Swedish Orphan ( SOBI.SE )
The new format for this report introduces a list of Shorts displayed in the Sector Score Cards. It Includes:
Solvay ( SOL.BE ): Solvay’s three divisions suffering from adverse FX and higher raw materials, offsetting volume growth.
Adidas ( ADSX.DE ): Topping characteristics. / Short term momentum eroding / (Too) high expectations from the street.
Renault ( RENU.FR ): Momentum deteriorating due to escalating trade tensions between the U.S. and China / Negative newsflow surrounding the alliance between Renault and Nissan / Highly exposed to EM currencies.
Essity ( ESSI.SE ): Raw material price increases, particularly pulp, putting pressure on margins / Aggressive expectations from sell-side analysts.
Siltronic ( WAFX.DE ): Ongoing concerns over iPhone production adjustments, falling NAND prices, and softer demand in the cryptocurrency space.